May 21, 2025
,
12:00 pm ET, 9:00 am PT
Clearmind is proud to host Rick Doblin and Robin Carhart-Harris in a timely discussion exploring how evolving FDA policies and shifting political landscapes impact psychedelic science and business.
Learn MoreFebruary 3, 2022
Clearmind is proud to host Dr. Gabor Maté to discuss Alcoholism, Trauma, and Clearmind’s candidate treatments
Learn MoreJanuary 26, 2022
Clearmind’s Management Team Explained the Process Required by the FDA to Approve Clearmind’s MEAI as Medicine
Learn MoreDecember 8, 2021
Clearmind’s Management Answers Questions Related to the Potential Treatment for Alcohol Use Disorder
Learn More